Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Diabetes Care Publish Ahead of Print published online ahead of print March 28, 2008
DOI: 10.2337/dc08-0194
This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc08-0194v1
31/7/1389    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gouni-Berthold, I.
Right arrow Articles by Krone, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gouni-Berthold, I.
Right arrow Articles by Krone, W.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Gender Disparities in the Treatment and Control of Cardiovascular Risk Factors in Type 2 Diabetes

Ioanna Gouni-Berthold, MD1, Heiner K. Berthold, MD, PhD2, Christos S. Mantzoros, MD3, Michael Böhm, MD4 and Wilhelm Krone, MD1

1Department of Internal Medicine II, University of Cologne, Germany
2University of Bonn, Clinical Pharmacology, Germany
3Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
4Department of Internal Medicine III, University of Homburg/Saar, Germany

ioanna.berthold{at}uni-koeln.de

ABSTRACT

Objective: To assess whether gender differences exist in the effective control and medication treatment intensity of cardiovascular disease (CVD) risk factors.

Research Design and Methods: Cross-sectional analysis including 44,893 patients with type 2 diabetes (51% women). Endpoints included uncontrolled CVD risk factors [LDL-C ≥130 mg/dl; systolic blood pressure (SBP) ≥140 mmHg; and hemoglobin-A1c (HbA1c) ≥8%] and the intensity of medical management in patients with uncontrolled CVD risk factors. Multiple-adjusted odds ratios were calculated after stratification for the presence of CVD (present in 39% of the patients).

Results: Women with CVD were less likely to have SBP, LDL-C and HbA1c controlled and less likely to receive intensive lipid-lowering treatment. Women without CVD were less likely than men to have LDL-C controlled with no differences in SBP or HbA1c control.

Conclusions: Women with diabetes and CVD have poorer control of important modifiable risk factors compared to men and receive less intensified lipid-lowering treatment.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.